Patent: Phospholipid Composition and Microbubbles and Emulsions Formed Using Same

MVT
Oct 31, 2017
1 min read

Recent Posts

Microvascular Therapeutics' CEO, Dr. Evan C Unger, featured in Authority Magazine.

Microvascular Therapeutic Announces Investment from the Nucleus Institute

December 4, 2025 — Salt Lake City, UT — The Nucleus Institute’s investment committee has unanimously approved and completed an investment in Microvascular Therapeutics Inc. (MVT) through MVT’s conver

New Preclinical Study Demonstrates Feasibility of Microbubble-Mediated, Non-Thermal Focused Ultrasound for Brain Tumor Ablation

Salt Lake City, UT –Wednesday November, 5 th 2025— Researchers from the University of Utah and Microvascular Therapeutics (MVT) will be presenting new preclinical data demonstrating that focused ultr

Comments

Commenting on this post isn't available anymore. Contact the site owner for more info.